• Drug Coverage
  • Hypertrophic Cardiomyopathy (HCM)
  • Vaccines: 2023 Year in Review
  • Eyecare
  • Urothelial Carcinoma
  • Women's Health
  • Hemophilia
  • Heart Failure
  • Vaccines
  • Neonatal Care
  • Type II Inflammation
  • Substance Use Disorder
  • Gene Therapy
  • Lung Cancer
  • Spinal Muscular Atrophy
  • HIV
  • Post-Acute Care
  • Liver Disease
  • Pulmonary Arterial Hypertension
  • Safety & Recalls
  • Biologics
  • Asthma
  • Atrial Fibrillation
  • Type I Diabetes
  • RSV
  • COVID-19
  • Cardiovascular Diseases
  • Breast Cancer
  • Prescription Digital Therapeutics
  • Reproductive Health
  • The Improving Patient Access Podcast
  • Blood Cancer
  • Ulcerative Colitis
  • Respiratory Conditions
  • Multiple Sclerosis
  • Digital Health
  • Population Health
  • Sleep Disorders
  • Biosimilars
  • Plaque Psoriasis
  • Leukemia and Lymphoma
  • Oncology
  • Pediatrics
  • Urology
  • Obstetrics-Gynecology & Women's Health
  • Opioids
  • Solid Tumors
  • Autoimmune Diseases
  • Dermatology
  • Diabetes
  • Mental Health

Consumers Across the Political Spectrum Want Lower Drug Prices, Poll Finds


Regardless of political affiliation, the public supports congressional action to allow the federal government to negotiate prices.

Lowering prescription drug prices is a top priority for Democrats, independents, and Republicans alike, according to Kaiser Family Foundation’s latest Health Tracking Poll.

Nearly nine in 10 (88%) of those who participated in the poll favor allowing the federal government to negotiate for lower prices on medications (see Figure 1), including three-fourths (77%) of Republicans, nine in 10 independents (89%) and 96% of Democrats. Majorities of Democrats (66%), independents (56%), and Republicans (58%) also say placing a limiting on out-of-pocket costs like prescription drug costs for seniors is a top priority..

Survey respondents say profits made by pharmaceutical companies are the largest factor contributing to the price of prescription drugs. This is followed by about seven in 10 who say the cost of research and development is a major factor contributing to the price, and about half saying that the cost of marketing and advertising is a major contributing factor to the cost of prescription drugs.

About half adults say they are currently taking at least one prescription drug and about a quarter say they currently take four of more prescription medications. Twice as many of those taking four or more prescription drugs say they have difficulty affording their prescriptions (35%), compared with adults who currently take three or fewer prescription medications (17%).

Credit: KFF Health Tracking Poll

Credit: KFF Health Tracking Poll

Related Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.